In partnership with
January 12, 2026
Built by a former cannabis regulator, Policy, Decoded helps operators read the policy terrain before it shifts beneath their feet.
Today’s edition tracks timing risk on two fronts: Republican attorneys general are signaling a litigation posture around Schedule III, and big banks are staying frozen until a formal federal trigger lands. We also cover the tightening vice on hemp-derived THC, with a federal deadline on the calendar, Texas floating $20,000 shop fees that function like market design, and Minnesota retailers budgeting around lost revenue if Washington does not adjust course. California’s departing regulator offers a rare look at the public service reality of building an agency at startup speed, with taxes, enforcement, lab integrity, and local access all on the same desk.
A new episode of The Hybrid dropped this morning, where we lay out our bets and tripwires for 2026.
Today’s edition is supported by Wispr Flow and Masterworks. To sponsor Policy, Decoded and reach the executives, investors, and policymakers who read this briefing, reply to this email and we will send details.
⚖️ Schedule III Court Risk
🏦 Banking Stays Frozen
🍹 Federal Deadline Pressure
Watch the dates. Ignore the noise.
Dictate prompts and tag files automatically
Stop typing reproductions and start vibing code. Wispr Flow captures your spoken debugging flow and turns it into structured bug reports, acceptance tests, and PR descriptions. Say a file name or variable out loud and Flow preserves it exactly, tags the correct file, and keeps inline code readable. Use voice to create Cursor and Warp prompts, call out a variable like user_id, and get copy you can paste straight into an issue or PR. The result is faster triage and fewer context gaps between engineers and QA. Learn how developers use voice-first workflows in our Vibe Coding article at wisprflow.ai. Try Wispr Flow for engineers.
Start here — the day’s most important development, decoded for impact.
📌 What Happened: Nicole Elliott, California’s inaugural Department of Cannabis Control director, gave an exit interview as she transitioned out of the role after years running the nation’s largest legal cannabis market. She describes success in the unsexy terms that actually matter: build an institution that reflects statute, withstands scrutiny, and keeps working when the founder leaves the room. She talks about the job spilling beyond licensing into tax debates, local access, equity support, environmental work, and enforcement coordination across agencies that do not share the same incentives. On taxes, she is frank about price sensitivity and how quickly the illicit market exploits every extra cost layer the legal market absorbs. On intoxicating hemp, she defends California’s push for one coherent safety lane because the public does not care which acronym regulates the product that lands in their hands. On labs and recalls, she acknowledges criticism and describes the slow due-process work of investigations, data systems, and proactive sampling that has to hold up when the state is challenged.
💡 Why It Matters: This job is public service delivered at startup speed, except you do not get to fail fast. You build the bureaucracy while operating it, with administrative law as the guardrail and politics as the weather. Lawmakers call, and some calls are earnest oversight, while others are politics in a cleaner wrapper, faster licensing for a favored project, a softer landing for someone back home, an enforcement angle that helps somebody’s narrative. Your staff hears all of it too, and they are the ones who have to execute decisions in the field and sign their names to work that will be pulled in public records. Add local control to the mix and you get cannabis deserts that feed illicit demand, then blame that floats back to the state anyway. This is why durability is the true deliverable, process that treats people equally, protects consumers, and gives the market something stable enough to adapt to.
🧠 THC Group Take: I got to know Nicole through our overlapping tenures and always respected her style and approach: direct, smart, sincere, and absolutely committed to mission. She reminded me of the best of our former peers, the ones who can speak plainly without being performative and can take pressure without letting it bend the work. That matters because cannabis regulation is a job where the work is rarely rewarded in the moment, and almost always judged in public. We ask regulators to build safe systems, keep access moving, take heat from every direction, and do it all with perfect consistency, even when statutes are vague and the market is changing faster than our rules can keep up. A little patience and empathy for public servants goes a long way, not because agencies deserve a free pass, but because serious oversight is easier when the conversation is grounded in what the job actually requires. Nicole’s instinct was to build systems that outlast the moment: clear standards, clean data, disciplined investigations, and decisions that hold up when challenged. California loses something real when a founding director steps away, and California will still benefit from her work for a long time because durable institutions keep paying dividends after the title changes.
Fast-moving headlines, flagged for what matters.
A coalition of Republican state attorneys general led by Nebraska Attorney General Mike Hilgers is pushing back on the White House direction to complete Schedule III rulemaking. Their objections lean on youth exposure and impaired driving and signal that legal and political escalation is on the table. Rescheduling will turn on process and timing, and courtroom pressure can turn the effective date into the real fight. Companies modeling 280E relief and research tailwinds should plan for a noisy runway even if the federal track keeps moving. Net effect: delay risk and cautious capital, not an overnight market unlock. (Lexology)
Major banks are still declining cannabis accounts after the rescheduling directive because an executive order does not change compliance obligations by itself. A JPMorgan internal memo cited in reporting says the bank will wait for a formal Schedule III action before revisiting its posture. Bank compliance teams also read the federal move as medical-focused, which leaves adult-use risk where it has been. Operators still face cash-heavy operations, limited credit, and expensive workarounds while Congress keeps SAFER Banking as the cleaner fix. Expect status quo friction until a legal trigger arrives, not a signal. (MJBizDaily)
Rescheduling remains a balance sheet story for marijuana businesses because it can change tax posture and underwriting narratives even without legalization. Congress tightening around intoxicating hemp is creating fresh product liability and Directors and Officers exposure for companies built on now-questioned SKUs. Brokers are warning that policy language written under yesterday’s definitions may not match tomorrow’s regulatory baseline. That mismatch becomes real when a claim hits and a carrier reads exclusions against a changed rulebook. The near-term operating reality is an audit season for labels, testing, distribution chains, and governance documents. (Insurance Business)
Breweries, municipal liquor stores, and THC beverage brands are planning around a federal cap of 0.4 milligrams of total THC per container that takes effect November 12th. Fulton Brewing says hemp THC beverages now represent nearly half its sales, and its current products sit in the 3 to 10 milligram range. Business Insider reports Nowadays saw sales jump 270% in the first half of 2025 and is treating lobbying as core strategy as it tries to preserve restaurant and event channels. In Cook County, Minnesota’s Grand Marais Municipal Liquor Store reported $89,368 in low-potency hemp edible sales from January through November 2025, which turns federal timing into real local budgeting. This becomes a purchasing and inventory discipline story, with buyers limiting exposure until Washington clarifies whether a regulated lane survives. (WTIP)
Texas health officials proposed rules that would raise annual fees for hemp-derived THC retailers from $150 to $20,000 per location and manufacturers to $25,000 per facility. The package keeps a 21 and older age floor, requires age verification, and adds mandatory recall authority. Industry critics say the fee level functions like a market gate that small operators cannot clear, pushing consolidation fast. The rules also tighten testing and limits in ways opponents warn will wipe out much of the natural hemp flower supply chain and reward synthetic conversions. The immediate reality is a compliance cliff created through rulemaking after the Legislature failed to land a deal. (Texas Tribune)
Wisconsin Republicans are split between an outright ban on intoxicating hemp and a regulated lane that keeps products on shelves under tighter controls. One camp is pushing bills that would track a federal clampdown, while another wants an alcohol-style framework with taxes and a three-tier separation that would reshape business models. A bipartisan approach tied to Sen. Pat Testin emphasizes adult-only access, independent lab testing, and packaging standards aimed at building a workable state program. Public hearings have put the divide on the record and forced legislators to pick a lane in public. That leaves compliant low-dose operators planning around politics, not just compliance. (Wisconsin Examiner)
The Cannabis Control Commission chair and chief of research are pitching a statewide Center for Cannabis Research and Policy to bring clinical work, public health, and social policy under one coordinated roof. The concept is right because Massachusetts has the scale, the talent, and the lived experience of a mature market, yet clinicians and regulators still operate with more folklore than durable evidence. The execution risk is real, since building a credible research institution requires grant-ready infrastructure, steady governance, and a culture that survives normal agency churn. If the Commission cannot accept grants as structured today, claiming that they’ve applied for and been awarded them already reads like starting construction without permits and hoping the paperwork catches up later. The fix is straightforward: house the center in a university or independent entity that can receive and administer funds cleanly, then formalize the Commission’s role as convenor and data partner. (The Boston Globe)
Six years after Illinois sold legalization as a repair project, many social equity license holders are still stuck in a cash-and-control trap. The state can award paper opportunity, yet it cannot force affordable real estate, workable financing, or fair management deals once the licenses hit the street. Operators describe a market where delays, high buildout costs, and scarce banking push them toward predatory capital or lopsided partnerships that drain the upside. Equity fails quietly when the system prizes licensing milestones over sustainable operations. Illinois can keep celebrating who won, or it can measure who opened, who survived year two, and who actually built wealth. The credibility test now is whether equity becomes durable ownership rather than a ceremonial label. (Crain’s Chicago Business)
The founder of a company selling shipping containers fitted for cannabis cultivation agreed to pay a $100,000 civil penalty and accept a five-year officer-and-director bar to settle SEC charges. The SEC alleged he concealed business relationships and sold unregistered investments tied to the container model. The pattern is familiar in cannabis-adjacent capital raising where related-party arrangements and revenue claims become the weak seam. Regulators tend to focus on who controlled the issuer and what investors were told about conflicts. Expect tougher diligence on control, disclosures, and whether the instrument should have been registered. (Bloomberg Law)
Colorado regulators issued two recalls tied to chlorfenapyr, a pesticide banned in the state’s cannabis supply chain. One recall covered flower from Rotation Farms sold across nineteen dispensaries after follow-up testing found levels above limits. A second notice flagged a specific concentrate batch associated with Egozi sold at one Colorado Springs dispensary. Consumers were told to return or destroy affected products and report adverse effects. The practical consequence is tighter scrutiny of pesticide controls and supplier verification before the next inspection becomes another recall. (Westword)
Maryland regulators fined a Baltimore dispensary $10,000 after an investigation found seed-to-sale tracking failures and missed required physical inventories. The consent order cites improper inventory tracking in Metrc and a lapse in monthly physical counts across multiple months in 2024. The case began with an inspection that pulled point-of-sale records, Metrc entries, and video review into the same audit frame. Tracking failures look small until they become a diversion story regulators feel obligated to chase. The operational result is higher inspection temperature and more corrective action plans tied to inventory controls and staff training.. (Outlaw Report)
A bill in the Nebraska Legislature would convert the Medical Cannabis Commission from an appointed body into an elected one. Supporters frame the move as an accountability fix after frustration with implementation pace and early rule choices. A companion proposal would add statutory immunity for health care practitioners tied to medical cannabis recommendations under the voter-approved framework. Elections change incentives fast and make program design a public campaign issue. That sets up a louder 2026 struggle over who controls the guardrails and how quickly patients see access that works. (Hastings Tribune)
Hawaii lawmakers are again circling cannabis legalization, with talk shifting from a hard legislative lift to a voter decision. House Judiciary and Hawaiian Affairs Chair David Tarnas is signaling a constitutional amendment route that would put the question to the public after years of stalled bills. That path still demands a two-thirds vote in each chamber, so leadership support becomes the real gatekeeper long before any campaign begins. The timing is sharp because it lands in an election year and in a session already crowded with tax and budget politics. The near-term consequence is that stakeholders start planning for ballot persuasion and coalition discipline while the Legislature decides whether it wants to own the policy or hand it to voters. (Honolulu Civil Beat)
Kentucky lawmakers filed a decriminalization and clean slate bill targeting simple possession and certain low-level records. House Bill 198 would exempt a personal-use quantity from civil or criminal penalty and create a retroactive expungement pathway for qualifying convictions. The measure was introduced January 7th and sent to the House Committee on Committees. The policy strategy is to move criminal justice posture while the state continues building medical infrastructure. The hinge is leadership willingness to force a day-one behavior change across prosecutors and courts. (Fox56)
Thailand is moving toward tighter cannabis rules that would confine sales to medical channels such as hospitals and pharmacies and restrict access for tourists. Officials are reacting to a market that expanded quickly after 2022, with cannabis becoming common in everyday venues and tourism demand growing around it. The government has already leaned into prescription requirements and purchase limits, and the new push would narrow the retail footprint further. The politics are hard to miss because the leader tied to legalization is now selling the crackdown as a public order reset ahead of elections. The consequence is a compliance squeeze and rapid consolidation that leaves small retailers and tourist-facing operators with the shortest runway. (Bloomberg)
An op-ed argues pre-rolls have become a dependable retail driver because they are easy to merchandise and easy for consumers to choose. It frames pre-rolls as a low-friction way to trial new brands and strains without committing to larger flower purchases. The author pushes assortment discipline across strain types, sizes, and price points to lift repeat buying. Retailers also get a clean data loop because pre-roll velocity shows what is working without confusing category signals. The operational result is merchandising power shifting toward the SKUs that move fast in a price-compressed market. (Marijuana Moment)
Wall Street Isn’t Warning You, But This Chart Might
Vanguard just projected public markets may return only 5% annually over the next decade. In a 2024 report, Goldman Sachs forecasted the S&P 500 may return just 3% annually for the same time frame—stats that put current valuations in the 7th percentile of history.
Translation? The gains we’ve seen over the past few years might not continue for quite a while.
Meanwhile, another asset class—almost entirely uncorrelated to the S&P 500 historically—has overall outpaced it for decades (1995-2024), according to Masterworks data.
Masterworks lets everyday investors invest in shares of multimillion-dollar artworks by legends like Banksy, Basquiat, and Picasso.
And they’re not just buying. They’re exiting—with net annualized returns like 17.6%, 17.8%, and 21.5% among their 23 sales.*
Wall Street won’t talk about this. But the wealthy already are. Shares in new offerings can sell quickly but…
*Past performance is not indicative of future returns. Important Reg A disclosures: masterworks.com/cd.
From the hearing room to the comment section — we’re watching it all.
🎵 A music history piece tracks one of the earliest mainstream song references to weed, a reminder that cannabis normalization did not start with dispensaries, it started with culture quietly teaching people what was ordinary. That cultural memory matters now because regulation keeps trying to draw bright lines around a substance that has lived in the open for decades, just unevenly enforced. (Far Out Magazine)
📈 Big market forecast press releases keep circulating, and they are often built from generic templates that mix real cannabis trends with filler language and questionable assumptions. They can still move boardroom conversations, so treat them as noise unless the underlying methodology and inputs are clear. Capital decisions still turn on state-by-state margin math, tax posture, enforcement risk, and access to banking, not a headline CAGR. (openPR)
🏋️♂️ Cannabis is showing up in fitness culture as a wellness tool tied to focus, pain management, and recovery, with users treating it like any other routine choice. The safety hinge is impairment, since the article puts responsibility and no driving at the center and warns that higher doses can undercut coordination and motivation. As normalization spreads into gyms and weekend athletics, policymakers and employers will face sharper questions about impairment standards, venue rules, and what responsible adult use looks like in everyday life. (Grants Pass Tribune)